Published in Science on March 06, 1992
Venous Thromboembolism in Myotonic Dystrophy Type 1 (DM1-VTE) | NCT03424460
The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol (1996) 5.41
Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J (1996) 5.14
Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol (1995) 4.04
Muscleblind proteins regulate alternative splicing. EMBO J (2004) 4.01
The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol (2001) 3.68
Comparative genomics and molecular dynamics of DNA repeats in eukaryotes. Microbiol Mol Biol Rev (2008) 3.35
Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci U S A (1997) 3.18
Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet (1992) 2.85
A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet (1996) 2.83
The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. J Biol Chem (2008) 2.60
Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet (1993) 2.42
Trinucleotide repeats associated with human disease. Nucleic Acids Res (1997) 2.35
The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet (1992) 2.15
Gene conversion plays the major role in controlling the stability of large tandem repeats in yeast. EMBO J (1996) 2.14
Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization. Mol Cell Biol (1998) 2.08
CTG repeat instability and size variation timing in DNA repair-deficient mice. EMBO J (2003) 1.96
Instability versus predictability: the molecular diagnosis of myotonic dystrophy. J Med Genet (1992) 1.94
Non-coding RNAs in the nervous system. J Physiol (2006) 1.87
Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet (1993) 1.86
Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet (2004) 1.85
Evidence for anticipation in schizophrenia. Am J Hum Genet (1994) 1.85
Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J (2006) 1.80
Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet (1994) 1.71
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology (2010) 1.67
Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci U S A (1997) 1.66
Orientation dependence of trinucleotide CAG repeat instability in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.63
Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet (1995) 1.62
Premutation allele pool in myotonic dystrophy type 2. Neurology (2008) 1.61
Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet (1995) 1.60
TRDB--the Tandem Repeats Database. Nucleic Acids Res (2006) 1.57
Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J Med Genet (1994) 1.54
Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes. Am J Hum Genet (1993) 1.50
How is the Human Genome Project doing, and what have we learned so far? Proc Natl Acad Sci U S A (1995) 1.50
Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J Med Genet (1992) 1.49
Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy. Dev Med Child Neurol (2015) 1.47
Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet (1994) 1.46
Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. Proc Natl Acad Sci U S A (1997) 1.45
The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol (2013) 1.45
An allele of RFA1 suppresses RAD52-dependent double-strand break repair in Saccharomyces cerevisiae. Genetics (1999) 1.44
Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching. J Am Chem Soc (2012) 1.44
Neurodegeneration the RNA way. Prog Neurobiol (2011) 1.43
Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations. J Med Genet (1992) 1.41
Cancer risk among patients with myotonic muscular dystrophy. JAMA (2011) 1.38
High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany. J Neurol (2008) 1.37
HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence. Nucleic Acids Res (2005) 1.37
Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet (2011) 1.33
MSH2-dependent germinal CTG repeat expansions are produced continuously in spermatogonia from DM1 transgenic mice. Mol Cell Biol (2004) 1.30
Codon reiteration and the evolution of proteins. Proc Natl Acad Sci U S A (1994) 1.29
Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). Am J Hum Genet (1993) 1.28
The unstable repeats--three evolving faces of neurological disease. Neuron (2013) 1.26
Myotonic dystrophy: the role of RNA CUG triplet repeats. Am J Hum Genet (1999) 1.24
Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest (1997) 1.23
MSH2 ATPase domain mutation affects CTG*CAG repeat instability in transgenic mice. PLoS Genet (2009) 1.22
DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest (1999) 1.20
Repeat-associated non-ATG (RAN) translation in neurological disease. Hum Mol Genet (2013) 1.20
The GAA triplet-repeat is unstable in the context of the human FXN locus and displays age-dependent expansions in cerebellum and DRG in a transgenic mouse model. Hum Genet (2006) 1.20
Segregation distortion of the CTG repeats at the myotonic dystrophy locus. Am J Hum Genet (1996) 1.19
Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle. Am J Pathol (2008) 1.17
Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet (2012) 1.17
Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy. Prog Mol Subcell Biol (2006) 1.16
Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains. J Cell Biol (2007) 1.16
Gametic but not somatic instability of CAG repeat length in Huntington's disease. J Med Genet (1993) 1.15
Structure and dynamics of the DNA hairpins formed by tandemly repeated CTG triplets associated with myotonic dystrophy. Nucleic Acids Res (1996) 1.14
The human genome project. Proc Natl Acad Sci U S A (1993) 1.14
Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. J Transl Med (2010) 1.13
Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract. Am J Hum Genet (2003) 1.13
Recent advances in understanding muscular dystrophy. Arch Dis Child (1992) 1.12
RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity. Brain Res (2012) 1.11
Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology (2012) 1.10
Absence of myotonic dystrophy in southern African Negroids is associated with a significantly lower number of CTG trinucleotide repeats. J Med Genet (1994) 1.10
Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells. FASEB J (2010) 1.09
MKBP, a novel member of the small heat shock protein family, binds and activates the myotonic dystrophy protein kinase. J Cell Biol (1998) 1.09
Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD. J Cell Biol (2002) 1.09
Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord (2012) 1.08
If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD). Contemp Clin Trials (2011) 1.08
Somatic and germline instability of the ATTCT repeat in spinocerebellar ataxia type 10. Am J Hum Genet (2004) 1.08
Evidence for genetic heterogeneity in tuberous sclerosis: one locus on chromosome 9 and at least one locus elsewhere. Am J Hum Genet (1992) 1.07
Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J (1995) 1.07
A method for fast database search for all k-nucleotide repeats. Nucleic Acids Res (1994) 1.07
Therapeutics development in myotonic dystrophy type 1. Muscle Nerve (2011) 1.07
Comparison of CTG repeat length expansion and clinical progression of myotonic dystrophy over a five year period. J Med Genet (1995) 1.07
RNA-mediated toxicity in neurodegenerative disease. Mol Cell Neurosci (2012) 1.07
Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders. Curr Opin Genet Dev (2014) 1.06
New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats. Nucleic Acids Res (2011) 1.06
Negative expansion of the myotonic dystrophy unstable sequence. Am J Hum Genet (1993) 1.04
The genetic background of anticipation. J R Soc Med (1995) 1.03
Presymptomatic diagnosis of myotonic dystrophy. J Med Genet (1992) 1.02
GSK3β mediates muscle pathology in myotonic dystrophy. J Clin Invest (2012) 1.02
Gastrointestinal manifestations in myotonic muscular dystrophy. World J Gastroenterol (2006) 1.01
Embryonic morphogenesis in Caenorhabditis elegans integrates the activity of LET-502 Rho-binding kinase, MEL-11 myosin phosphatase, DAF-2 insulin receptor and FEM-2 PP2c phosphatase. Genetics (2000) 1.01
The muscular dystrophies: from genes to therapies. Phys Ther (2005) 1.01
Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec. Hum Genet (2005) 1.01
Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features. PLoS One (2008) 1.01
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies. Acta Myol (2013) 1.01
Deregulated microRNAs in myotonic dystrophy type 2. PLoS One (2012) 1.01
Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus. PLoS Genet (2012) 1.01
MBNL proteins and their target RNAs, interaction and splicing regulation. Nucleic Acids Res (2014) 1.00
Woodchuck post-transcriptional element induces nuclear export of myotonic dystrophy 3' untranslated region transcripts. EMBO Rep (2005) 1.00
De novo myotonic dystrophy mutation in a Nigerian kindred. Am J Hum Genet (1995) 1.00
Analysis of meiotic segregation, using single-sperm typing: meiotic drive at the myotonic dystrophy locus. Am J Hum Genet (1996) 1.00
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell (1991) 12.27
Experimental annotation of the human genome using microarray technology. Nature (2001) 10.39
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature (1992) 7.68
Polypeptides of the tail fibres of bacteriophage T4. J Mol Biol (1971) 6.97
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
Synthesis of ribonucleic acid and protein in plasmid-containing minicells of Escherichia coli K-12. J Bacteriol (1971) 5.35
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A (1996) 4.45
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature (1992) 4.44
Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet (1997) 4.12
Virus assembly. Annu Rev Biochem (1975) 3.93
Physical and genetic mapping of a novel chromosome 19 ERCC1 marker showing close linkage with myotonic dystrophy. Genomics (1991) 3.72
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Assembly of the tail of bacteriophage T4. J Mol Biol (1968) 3.38
Triplet repeat mutations in human disease. Science (1992) 3.35
Characterization of a murine gene expressed from the inactive X chromosome. Nature (1991) 3.21
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
Prospective randomised controlled trial of methods of call and recall for cervical cytology screening. BMJ (1989) 3.11
Mechanism of head assembly and DNA encapsulation in Salmonella phage p22. I. Genes, proteins, structures and DNA maturation. J Mol Biol (1973) 3.10
The nucleotide sequence of the Escherichia coli K12 dnaJ+ gene. A gene that encodes a heat shock protein. J Biol Chem (1986) 3.04
Pectin esterification is spatially regulated both within cell walls and between developing tissues of root apices. Planta (1990) 3.03
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90
Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science (1993) 2.75
How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ (2001) 2.74
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology (2004) 2.70
RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem (2000) 2.65
Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet (2000) 2.60
Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J (1991) 2.56
Disodium cromoglycate (Intal). Adv Drug Res (1970) 2.56
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA (1999) 2.56
The DNA translocating vertex of dsDNA bacteriophage. Annu Rev Microbiol (1985) 2.55
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis (2000) 2.55
Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition. Nat Biotechnol (1996) 2.52
Catalytic head assembling protein in virus morphogenesis. Nature (1974) 2.51
Popular diets: a scientific review. Obes Res (2001) 2.49
Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studies. Neurology (2000) 2.48
P22 morphogenesis. I: Catalytic scaffolding protein in capsid assembly. J Supramol Struct (1974) 2.44
Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb Pathog (1997) 2.41
Mechanism of head assembly and DNA encapsulation in Salmonella phage P22. II. Morphogenetic pathway. J Mol Biol (1973) 2.40
The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet (1998) 2.39
Anthropometric and biochemical changes during pregnancy in Asian and European mothers having light for gestational age babies. Br J Obstet Gynaecol (1981) 2.35
Nucleation and growth phases in the polymerization of coat and scaffolding subunits into icosahedral procapsid shells. Biophys J (1993) 2.33
Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol (2001) 2.32
High-throughput isolation of Caenorhabditis elegans deletion mutants. Genome Res (1999) 2.29
Two infant vision screening programmes: prediction and prevention of strabismus and amblyopia from photo- and videorefractive screening. Eye (Lond) (1996) 2.25
SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet (2001) 2.20
Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration. Ophthal Plast Reconstr Surg (2007) 2.19
Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology (2006) 2.17
Three-dimensional transformation of capsids associated with genome packaging in a bacterial virus. J Mol Biol (1993) 2.16
Crystal cataracts: human genetic cataract caused by protein crystallization. Proc Natl Acad Sci U S A (2001) 2.11
Deletion and amplification of the HGPRT locus in Chinese hamster cells. Mol Cell Biol (1983) 2.10
Teaching and assessing ethics and law in the dental curriculum. Br Dent J (1999) 2.09
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun (1995) 2.06
Genetic control of bacteriophage T4 baseplate morphogenesis. I. Sequential assembly of the major precursor, in vivo and in vitro. J Mol Biol (1975) 2.03
Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Vaccine (2000) 2.00
Scaffolding protein regulates the polymerization of P22 coat subunits into icosahedral shells in vitro. J Mol Biol (1988) 1.99
The structural organization of DNA packaged within the heads of T4 wild-type, isometric and giant bacteriophages. Cell (1978) 1.99
Bacteriophage assembly. Fed Proc (1968) 1.96
Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. EuroIntervention (2009) 1.94
A long-range restriction map of the human chromosome 19q13 region: close physical linkage between CKMM and the ERCC1 and ERCC2 genes. Am J Hum Genet (1990) 1.94
Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet (1991) 1.93
Disulphide-bonded intermediate on the folding and assembly pathway of a non-disulphide bonded protein. Nat Struct Biol (1997) 1.92
Sequence analysis and transcriptional regulation of the Escherichia coli grpE gene, encoding a heat shock protein. Nucleic Acids Res (1988) 1.87
Pentanucleotide repeat length polymorphism at the human CD4 locus. Nucleic Acids Res (1991) 1.85
The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine (2000) 1.82
Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology (2005) 1.79
Structure of phage P22 coat protein aggregates formed in the absence of the scaffolding protein. J Mol Biol (1978) 1.79
Recombinational repair in yeast: functional interactions between Rad51 and Rad54 proteins. EMBO J (1997) 1.78
Local rule-based theory of virus shell assembly. Proc Natl Acad Sci U S A (1994) 1.77
Genetic control of bacteriophage T4 baseplate morphogenesis. III. Formation of the central plug and overall assembly pathway. J Mol Biol (1975) 1.76
Whole proteome pI values correlate with subcellular localizations of proteins for organisms within the three domains of life. Genome Res (2001) 1.75
Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet (1995) 1.74
Global suppression of protein folding defects and inclusion body formation. Science (1991) 1.74
Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics (1995) 1.74
Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol (2001) 1.74
An analysis of first-time enquirers to the CancerBACUP information service: variations with cancer site, demographic status and geographical location. Br J Cancer (1999) 1.68
Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and nonbleeding visible vessel: an analysis of two prospective clinical trials. Am J Gastroenterol (1998) 1.66
Role of the scaffolding protein in P22 procapsid size determination suggested by T = 4 and T = 7 procapsid structures. Biophys J (1998) 1.65
Bacteriophage T4 tail assembly: proteins of the sheath, core and baseplate. J Mol Biol (1973) 1.63
Characterization of transferable plasmids from Shigella flexneri 2a that confer resistance to trimethoprim, streptomycin, and sulfonamides. Plasmid (1986) 1.63
Medical evidence in child abuse. Arch Dis Child (1986) 1.62
Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet (1995) 1.62
Efficacy of albuterol in the management of bronchiolitis. Pediatrics (1994) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Formation of aggregates from a thermolabile in vivo folding intermediate in P22 tailspike maturation. A model for inclusion body formation. J Biol Chem (1988) 1.59
Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA (1993) 1.58
Huntington's disease--like 2 can present as chorea-acanthocytosis. Neurology (2003) 1.57
Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol (1997) 1.56
The distribution of 2-acetamido-2-deoxy-D-glucose residues in mammalian heparins. Carbohydr Res (1972) 1.55
Bacteriophage T4 tail assembly: structural proteins and their genetic identification. J Mol Biol (1973) 1.55
An integrated metric physical map of human chromosome 19. Nat Genet (1995) 1.54
Ethnic distribution of myotonic dystrophy gene. Lancet (1991) 1.54